Investing Stocks أون سمiconductors · ON Disc Medicine surge 60% on positive Phase 3 trial for rare sunlight disorder Oct 19, 2026 2:25 PM · Investing Disc Medicine surge 60% on positive Phase 3 trial for rare sunlight disorder Original source: Investing